Naloxone Take Home Kits by Canadian Hospital Specialties Ltd. — recall 75833
Health Canada — Medical Devices · Canada · 2024-08-20 · Type I
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Reported risk: The product contains the naloxone drug. The monograph for these drug products indicates that it should be re-administered in 2-3 minutes after the first dose whereas the save me card included in this kit for training purposes does not align with this re-administration time. As this is conflicting information and can cause confusion, we will revise the insert to reflect the 2-3 min requirement per the drug monograph. Update: It is important to note that these NTH Kits are not being removed from the Canadian market so as not to disrupt access to naloxone, a potentially life-saving drug. Recall Start Date: July 4, 2024
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.